Drugs / Salt and Water
Salt and Water
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | STERILE WATER | — | 1974-12-31 | fda.gov ↗ |
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT05109000 | Nov 2021 → Jan 2022 | — | Jeffrey Alan Klein, MD | Unknown | No outcome recorded |
| Phase 4 | NCT02084771 | Oct 2014 → Dec 2015 | acute kidney injury | Ottawa Hospital Research Institute | Withdrawn | No outcome recorded Stop: Enrollment |
| Comparator or background therapy2 trials | ||||||
| — | NCT01682928 Comparator | Aug 2012 → Dec 2014 | oligohydramnios | Pediatrix | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT01513447 Comparator | Dec 2011 → Dec 2013 | — | Northwestern University | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Salt and Water | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02084771 ↗ |
| Known as | Bacteriostatic Sodium Chloride | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05109000 ↗ |
| Known as | sterile water | “Patients allocated to the study group will receive sterile water, and those allocated to the control group will receive sterile normal saline solution.” NCT01513447 ↗ |
| Known as | Water | “1 Liter Water PO over 2 hours” NCT01682928 ↗ |
| Route | Oral | “1 Liter Water PO over 2 hours” NCT01682928 ↗ |